- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:46 | US launches probe that could set stage for pharma tariffs | ||
| Mo | Safety worries spur Pfizer to drop another obesity pill | ||
| Mo | Third Harmonic outlines plans for dissolution | ||
| Mo | Pharma bosses face down investor angst on tariffs, HHS chaos | ||
| Mo | Verve's second swing at gene editing for heart disease shows early promise | ||
| Mo | The critical role of evidence-based databases in pharmacogenomics: Ensuring accuracy, consistency and relevance | ||
| Mo | Translating FDA guidance into action: Regulatory considerations for orphan drug developers | ||
| Mo | Mining the hidden gems in unstructured EMR data | ||
| Fr | Amgen says Imdelltra extended survival; Parker Institute adds new leaders | ||
| Fr | FDA plans to phase out animal testing for some drugs | ||
| Fr | Amid tariff turmoil, Novartis commits to spending $23B on U.S. manufacturing | ||
| Do | Tempest seeks strategic alternatives as cash runs out for Phase 3 trial | ||
| Do | Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts | ||
| Mi | Trump pauses most reciprocal tariffs, hikes China's further | ||
| Mi | Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division | ||
| Mi | Trump says 'major' tariffs coming on pharmaceuticals | ||
| 08.04. | US risks losing biotech edge to China, report warns | ||
| 08.04. | Rallybio discontinues lead drug for rare maternal disorder | ||
| 08.04. | Tango Therapeutics cuts nearly one-fifth of staff | ||
| 08.04. | Judge permanently blocks Trump admin plan to cap NIH funding, setting up appeals battle | ||
| 07.04. | RFK Jr. won't appear before Senate panel this week | ||
| 07.04. | GSK targets neurodegenerative diseases with latest licensing deal | ||
| 07.04. | Obesity drug data helps Rhythm defy market slide | ||
| 07.04. | Trump rejects Biden-era plan to let Medicare cover obesity drugs | ||
| 04.04. | Tariffs send healthcare industry into 'unchartered waters' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
